Clinical Trial Update: An Open-label, Single-arm, Single-center Study to Evaluate the Diagnostic Efficacy of a Novel PET Probe, 68Ga-SFB6-ZN01, in Patients With Malignant Tumors [EARLY_Phase 1]

View source ↗

Summary

An open-label, single-arm, single-center Phase 1 study will evaluate the diagnostic efficacy of the novel PET tracer 68Ga-SFB6-ZN01 in patients with malignant t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• 68Ga-SFB6-ZN01

Snippet

Sponsor: Zhongnan Hospital | Conditions: Neoplasms | EARLY_Phase 1 | Status: NOT_YET_RECRUITING